Source: Arthrits & Rheumatism. Conference titles: Annual Scientific Meeting. Unidade: FM
Assunto: ÓXIDO NÍTRICO (APLICAÇÕES TERAPÊUTICAS)
ABNT
LAURINDO, Ieda M. M. et al. Leflunomide (ARAVA) promotes reduction of serum nitric oxide metabolites in parallel with clinical improvement. Arthrits & Rheumatism, v. 44, n. 9 (Suppl), p. S216, 2001Tradução . . Acesso em: 28 maio 2024.APA
Laurindo, I. M. M., Novaes, G. S., Torigoe, D. Y., & Mello, S. B. V. (2001). Leflunomide (ARAVA) promotes reduction of serum nitric oxide metabolites in parallel with clinical improvement. Arthrits & Rheumatism, 44( 9 (Suppl), S216.NLM
Laurindo IMM, Novaes GS, Torigoe DY, Mello SBV. Leflunomide (ARAVA) promotes reduction of serum nitric oxide metabolites in parallel with clinical improvement. Arthrits & Rheumatism. 2001 ; 44( 9 (Suppl): S216.[citado 2024 maio 28 ]Vancouver
Laurindo IMM, Novaes GS, Torigoe DY, Mello SBV. Leflunomide (ARAVA) promotes reduction of serum nitric oxide metabolites in parallel with clinical improvement. Arthrits & Rheumatism. 2001 ; 44( 9 (Suppl): S216.[citado 2024 maio 28 ]